Pharmaceutical Executive
Episodes
Behind the Creative: Inspiring Award-Winning Creative
03 May 2021
Contributed by Lukas
Shaheed Peera, President, Founder and CEO of The Creative Floor Awards, London, and Global Creative Lead for Reckitt Benckiser ECom, talks about inspi...
Episode 81: Cancer Research Amid COVID
29 Apr 2021
Contributed by Lukas
Dr. Michele Cleary, CEO of the Mark Foundation for Cancer Research, discusses how the foundation has navigated COVID to help keep critical cancer rese...
Episode 80: Rugby Rules in Pharma
15 Apr 2021
Contributed by Lukas
John Furey, CEO of Imvax and an Editorial Advisory Board member for Pharm Exec, discusses some leadership principles he learned while playing rugby as...
Episode 79: Managing Quarantine Remotely
01 Apr 2021
Contributed by Lukas
Uche Iloeje, Vice President medical affairs Mirdametenib at SpringWorks Therapeutics, shares his experience after he became stranded in Nigeria for fi...
Episode 78: The Digital Denouement of COVID
18 Mar 2021
Contributed by Lukas
Paul Shawah, Executive Vice President of Strategy at Veeva Systems, looks back at the past year of the pandemic to see the digital transformation of p...
Episode 77: The Effects of AI on IP
04 Mar 2021
Contributed by Lukas
Kevin Buckley, founder of Torrey Pines Law Group, and Neil Thompson, a patent agent with the firm, discuss IP strategy as it relates to pharma and art...
Episode 76: Repatriating Pharma
18 Feb 2021
Contributed by Lukas
Joel Marcus, founder and executive chairman of Alexandria Real Estate Equities, and founder and CEO of Alexandria Venture Investments, discusses the d...
Episode 75: Protecting Pharma Through Cybersecurity
04 Feb 2021
Contributed by Lukas
Scott Nawrocki, managing director of digital investigations and cyber defense at Nardello & Co., discusses cybersecurity in pharma, including topi...
Episode 74: 2021 Industry Outlook
21 Jan 2021
Contributed by Lukas
Editorial Director, Lisa Henderson; European and online editor, Julian Upton; Senior Editor, Elaine Quilici ;and Assistant Editors of Pharmaceutical E...
Episode 73: Biotech’s IPO Steamroll
07 Jan 2021
Contributed by Lukas
Gregg Beloff, co-founder of Danforth Advisors, discusses the banner year biotech IPOs had in 2020, the drive behind that boom, and what the future of ...
Episode 72: Trying to Outpace Rare Disease
24 Dec 2020
Contributed by Lukas
Rich Horgan, founder and president of Cure Rare Disease(CRD), discusses how he sprang into action when his brother was diagnosed with Duchenne muscula...
Episode 71: Connecting With NPs and PAs
10 Dec 2020
Contributed by Lukas
Sacha Ward, chief client officer of Point of Care Network, discusses how COVID has affected the roles of nurse practitioners and physician assistants,...
Episode 70: Keeping Pharma Informed
26 Nov 2020
Contributed by Lukas
Krystle Buntemeyer, president of SCORR Marketing, and Bharat Mehta, co-founder of PharmaCompass, discuss a new, free online tool called Pipeline Prosp...
Episode 69: Fighting Influenza During COVID
12 Nov 2020
Contributed by Lukas
Dr. Gregg Sylvester, chief medical officer of Seqirus, discusses the importance of vaccinating against the seasonal flu amid the COVID pandemic, and h...
Episode 68: Rocking Garage Biotech
29 Oct 2020
Contributed by Lukas
Panna Sharma, CEO of Lantern Pharma, discusses garage biotech, what he’s learned from the culture, and how it might help transform certain areas of ...
Episode 67: Succeeding Through Adversity
15 Oct 2020
Contributed by Lukas
Sanjeev Luther, president and CEO of Rafael Pharmaceuticals, discusses how he managed to turn around a company on the brink of bankruptcy and advance ...
Episode 66: New Approach to Antithrombotics
01 Oct 2020
Contributed by Lukas
Dr. Neil Hayward, CEO and founder of eXlthera, is here to discuss his company, which is developing Factor XI inhibitor antithrombotics that are attack...
Episode 65: Creating a Path for Innovation
17 Sep 2020
Contributed by Lukas
George Baxter, CEO of Edinburgh Innovations, is here to discuss the company's commercialization model, and how his group is bringing innovation to mar...
Episode 64: The Complexities of Managing ADHD
03 Sep 2020
Contributed by Lukas
Jack Khattar, president and CEO of Supernus Pharmaceuticals, talks about his experience bringing ADHD drugs to market in a challenging environment.
Episode 63: Three Simple Principles to Improve Leadership
20 Aug 2020
Contributed by Lukas
Eric Turbiville, author of the recently published book “The Perfect Leadership Triad: How Top Executives Maximize Productivity through People, Coach...
Episode 62: The Future of Pharma’s Supply Chain
06 Aug 2020
Contributed by Lukas
Kurt Orlofski, CEO of Pharmaceutical Associates Inc., discusses what the pharmaceutical supply chain might look like post COVID-19, and how companies ...
Episode 61: Preparing for Virtual High-Stakes Meetings
23 Jul 2020
Contributed by Lukas
Jim and Cindy DiBiasi, co-founders of 3D Communications, talk about how to prepare for virtual high-level meetings, such as important regulatory prese...
Episode 60: Leading With Compassion
09 Jul 2020
Contributed by Lukas
Tim Walbert, CEO of Horizon Therapeutics, shares his unique perspective on managing the Chicago location of the company through COVID-19, in light of ...
Episode 59: Using Tau to Target Alzheimer’s
25 Jun 2020
Contributed by Lukas
Janice Kranz, co-founder of Eikonizo Therapeutics, bring us up to date on how targeting tau to fight Alzheimer’s and other neurodegenerative disease...
Episode 58: Understanding FDA’s Gene Therapy Guidelines
11 Jun 2020
Contributed by Lukas
Dr. Jonathan Gertler, CEO of Back Bay Life Science Advisors, and Dr. Stephan Gauldie, Managing Director of Back Bay, talk about the new guidelines set...
Episode 57: Planning for Pharma’s New Normal
28 May 2020
Contributed by Lukas
Pratap Khedkar, managing principal of ZS Associates, talks about pharma’s scenario planning amid COVID-19 as it looks to settle into a new normal.
Episode 56: Killing Cancer Through Direct Injection
14 May 2020
Contributed by Lukas
Lew Bender, founder of Intensity Therapeutics and the inventor of Intensity’s DfuseRx platform technology, discusses the technology that allows the ...
Episode 55: Developing a Maternal RSV Vaccine
30 Apr 2020
Contributed by Lukas
Kathrin Jansen, Senior Vice President and Head of Vaccine Research and Development at Pfizer, talks about the challenges of creating a new maternal va...
Episode 54: Taking Advantage of Digital Marketing
15 Apr 2020
Contributed by Lukas
Chris Paquette, DeepIntent co-founder and CEO, talks about the evolution of digital marketing in pharma, specifically, how to approach data and techno...
Episode 53: Fabulous Pharma Females
02 Apr 2020
Contributed by Lukas
Barbara Ryan, founder of Barbara Ryan Advisors, a member of PharmExec’s editorial advisory board, and the founder of Fabulous Pharma Females discuss...
Episode 52: Cannabinoids
19 Mar 2020
Contributed by Lukas
Yuval Cohen, CEO of Corbus Pharmaceuticals, talks about cannabinoids, the differences between natural and synthetic products, and how biotechs and pha...
Episode 51: Combating Coronavirus
05 Mar 2020
Contributed by Lukas
Dr. Eric von Hofe, Chief Scientific Officer at NuGenerex Immuno-Oncology talks about the recent outbreak of Wuhan coronavirus around the world and how...
Episode 50: Pharma Pricing Climate in Washington
20 Feb 2020
Contributed by Lukas
Mike Strazzella, head of federal government relations for Buchanan Ingersoll & Rooney, talks about pricing issues in the pharmaceutical industry, ...
Episode 49: Navigate Emerging Markets with Data Science
06 Feb 2020
Contributed by Lukas
Pharm Exec speaks with Nigel Breakwell and Ben Randal, co-founders of Dot I/O Health. Nigel and Ben talk about how they’re using data science in the...
Episode 48: 2020 Industry Outlook
23 Jan 2020
Contributed by Lukas
Pharm Exec editors discuss the themes chosen for the January issue focusing on industry trends for the coming year.
Episode 47: Identifying Adherence Issues
09 Jan 2020
Contributed by Lukas
Heather Monte, Director of Operations for DirectRx, talks about the specialty pharma’s new Patient Scorecard, which aims to identify and improve adh...
Episode 46: Persistence and Planning Pays Off
19 Dec 2019
Contributed by Lukas
Julia Owens, co-founder and CEO of Millendo Therapeutics talks about how to keep a company on the path to success, even when there are bumps in the ro...
Episode 45: Getting Drug Approval Through FDA LPAD
05 Dec 2019
Contributed by Lukas
William Lewis, chairman and CEO of Insmed talks about the approval of the company’s drug Arikayce through the FDA’s Limited Population Pathway for...
Episode 44: Annual Pipeline Report
21 Nov 2019
Contributed by Lukas
Pharm Exec editors discuss the articles they focused on for the November Annual Pipeline Report.
Episode 43: Pharma Reputation
07 Nov 2019
Contributed by Lukas
Sven Klingemann, research director at Reputation Institute talks about pharma’s negative public perception and what the industry can do to improve i...
Episode 42: Establishing a New Drug Therapy
17 Oct 2019
Contributed by Lukas
Pharm Exec editors interview Mark Glickman, Chief Commercial Officer of Esperion Therapeutics. Glickman discusses the overall cholesterol-lowering spa...
Episode 41: The Patient Journey
03 Oct 2019
Contributed by Lukas
Jeannine Lynch, senior director at BioMarin Pharmaceuticals, oversees patient access services and talks with editors about the patient journey in rega...
Episode 40: Global Pharma Outlook
19 Sep 2019
Contributed by Lukas
Janssen’s company group chairman of Europe, Middle East, and Africa operations, Kris Sterkens speaks with Pharm Exec editors. Kris talks about his f...
Episode 39: CEO Builds Business With Compassion
05 Sep 2019
Contributed by Lukas
Apellis’ CEO and co-founder, Dr. Cedric Francois talks with editors about his unusual pharma journey, which has included research, clinical work, an...
Episode 38: Customer-Centric Innovation
22 Aug 2019
Contributed by Lukas
Christine Sakdalan, Head of Franchise Strategy and Customer Solutions at Janssen Pharmaceutical talks with Pharm Exec editors about how patient-centri...
Episode 37: Differentiating Yourself in Crowded Therapeutic Areas
08 Aug 2019
Contributed by Lukas
Pharm Exec editors sit down with Mark Velleca, CEO of G1 Therapeutics. In this episode, Mark talks about how he differentiates himself in the oncology...
Episode 36: A View from the Editors' Desks
25 Jul 2019
Contributed by Lukas
Pharm Exec editors share insights into what they've been working on this summer for the June, July, and August issues; plus a sneak peek into what's c...
Episode 35: Communicating Your Narrative with Healthcare Marketing
11 Jul 2019
Contributed by Lukas
Robert Finkel, the CEO of The FreshBlood Group talks with Pharm Exec editors about the positives and negatives of pharma’s marketing needs, the deta...
Episode 34: The Future of the Life Sciences Executive
21 Jun 2019
Contributed by Lukas
Cameron Turtle, Chief Business Officer of Eidos Therapeutics, Robin Toft, Founder and CEO of The Toft Group Executive Search and Sabrina Johnson, Pres...
Episode 33: Translationally Enabled Pharma
11 Jun 2019
Contributed by Lukas
Pharm Exec editors speak with Jigar Raythatha, CEO of Constellation Pharmaceuticals. He talks about his roles, the importance of having a Plan B in bi...
Episode 32: Change Your Behaviors, Change Your Health & Wellness
23 May 2019
Contributed by Lukas
Pharm Exec's European Editor, Julian Upton, speaks with Johnson & Johnson's Jennifer Turgiss, VP Behavior Science & Advanced Analytics group. ...
Episode 31: Ruling in Favor of Biotech
10 May 2019
Contributed by Lukas
Editor-in-Chief Lisa Henderson speaks with Bill Newell, CEO of Sutro Biopharma about his background in corporate law and how it helps him in his role ...
Episode 30: Challenges in Renal Disease Drug Development
25 Apr 2019
Contributed by Lukas
Pharm Exec editors interview Anna Sundgren, the renal disease strategy leader, Global Medicines Development at AstraZeneca, about the current CVRM lan...
Episode 29: Disease Prevention & Interception
11 Apr 2019
Contributed by Lukas
Pharm Exec's European Editor, Julian Upton, caught up with Ben Wiegand, head of J&J's World Without Disease Accelerator unit, at eyeforpharma Barc...
Episode 28: Digital Medication
28 Mar 2019
Contributed by Lukas
Michelle Maskaly and Christen Harm speak with Bill Carson, President & CEO of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPD...
Episode 27: Sensitive Topics in Pharma
15 Mar 2019
Contributed by Lukas
Pharm Exec editors talk with Seth Lederman, co-founder, CEO and chairman of Tonix Pharmaceuticals about how to navigate creating drugs for conditions ...
Episode 26: Patient Advocacy
01 Mar 2019
Contributed by Lukas
Pharm Exec editors sit down with Bob Ward, chairman and CEO of Eloxx Pharmaceuticals, to talk about his personal, as well as Eloxx’s, commitment to ...
Episode 25: China’s Pharma Growth
14 Feb 2019
Contributed by Lukas
Michelle Maskaly and Christen Harm talk with David Shao, CEO of Yisheng Biopharma, about what’s driving China’s exploding pharma and biotech indus...
Episode 24: 2019 Industry Trends
05 Feb 2019
Contributed by Lukas
Michelle Maskaly and Christen Harm sit down with Editor-in-Chief Lisa Henderson and European Editor Julian Upton to discuss the industry trends featur...
Episode 23: Mindfulness in Clinical Trial R&D
17 Jan 2019
Contributed by Lukas
Pharm Exec editors Michelle Maskaly and Christen Harm speak with Raymond Sanchez, senior vice president of Global Clinical Development at Otsuka Pharm...
Episode 22: Virtual Reality and Marketing in Healthcare
13 Dec 2018
Contributed by Lukas
Nicola Kayel, Vice President of Marketing at Salix Pharmaceuticals, speaks with Pharm Exec editors about the challenges and strategies for marketing d...
Episode 21: Southeast Biotech
29 Nov 2018
Contributed by Lukas
Jack Bailey, president of US pharmaceuticals for GlaxoSmithKline, talks with Christen Harm and Michelle Maskaly, about the biopharma landscape in the ...
Episode 20: Analyzing the Pharma Pipeline
08 Nov 2018
Contributed by Lukas
Pharm Exec Editorial Director Lisa Henderson and European Editor Julian Upton talk with Michelle Maskaly and Christen Harm about the magazine’s rece...
Episode 19: How a CEO pivots Their Company and Career
25 Oct 2018
Contributed by Lukas
Christen and Michelle talk with Mei Mei Hu, CEO of United Neuroscience, about how being open to pivoting from your original plan can create a number o...
Episode 18: Data’s Influence on the Pharma C-suite
11 Oct 2018
Contributed by Lukas
Michelle and Christen sit down with one of this year's Emerging Pharma Leaders, Christopher Boone, the head of real-world data and analytics center of...
Episode 17: Commercializing Research
27 Sep 2018
Contributed by Lukas
On Target Laboratories, CEO and Co-Founder, Martin R. Low and Philip S. Low, whose work the company is based off of and is also a co-founder of the co...
Episode 16: Specialty Pharma
13 Sep 2018
Contributed by Lukas
Pharm Exec’s Editor-in-Chief Lisa Henderson and European Editor Julian Upton join Christen Harm and Michelle Maskaly to talk about the topic of spec...
Episode 15: Impact of Robotics in Pharma
23 Aug 2018
Contributed by Lukas
Learn how pharma companies are using robotics and artificial intelligence when it comes to patient care, what the funding landscape is for businesses ...
Episode 14: Emerging Biotech in NYC
02 Aug 2018
Contributed by Lukas
Nancy Thornberry, CEO of Kallyope, talks with Michelle Maskaly and Christen Harm about New York City as an emerging hotspot for biotech incubators, an...
Episode 13: How to Run a Successful Clinical-Stage Pharma Startup
19 Jul 2018
Contributed by Lukas
Jeffrey Nau is CEO of Oyster Point Pharma, a clinical stage pharmaceutical company focused on developing commercial therapies dealing with parasympath...
Episode 12: Midwest Biotechs and Regenerative Medicine
06 Jul 2018
Contributed by Lukas
Gil Van Bokkelen, CEO and co-founder of Athersys, talks about a pivotal moment during medical school that led him and his co-founders to eventually la...
Episode 11: From Field to Boardroom with Former NFL Star Solomon Wilcots
25 Jun 2018
Contributed by Lukas
Former NFL star and current sports broadcaster, Solomon Wilcots talks about the intersection of sports and biopharma. He discusses traumatic brain inj...
Episode 10: Mentoring and Sponsoring
07 Jun 2018
Contributed by Lukas
Michelle Maskaly and Christen Harm host one of Pharm Exec's Emerging Pharma Leaders, Sabina Ewing, vice president of business technology for Pfizer, a...
Episode 9: 2018 PE Brands of the Year
24 May 2018
Contributed by Lukas
Michelle Maskaly and Christen Harm host the entire Pharmaceutical Executive editorial team on this episode, as we each talk about our Brands of the Ye...
Episode 8: CFO Insights From the Field
15 May 2018
Contributed by Lukas
Tim Sullivan, CFO of Apellis Pharmaceuticals, gives an inside look at what it takes to be the CFO of a development-stage biotech company, and what bus...
Episode 7: Big-Event Insights
26 Apr 2018
Contributed by Lukas
Pharm Exec editors discuss key takeaways from a variety of industry conferences that took place across the globe. Leadership Tip by Julia Cheek, CEO ...
Episode 6: The Pharma vs. Biotech Experience
12 Apr 2018
Contributed by Lukas
Christen Harm and Michelle Maskaly interview Lara Sullivan, founder and president of SpringWorks Therapeutics, about the differences in working for le...
Episode 5: Med Affairs Training
26 Mar 2018
Contributed by Lukas
Dr. William Soliman shares the story of how the Accreditation Council for Medical Affairs went from an idea in his head to a training program today th...
Episode 4: Outcomes-Based Contracting
16 Mar 2018
Contributed by Lukas
In this episode, Michelle Maskaly and Christen Harm talk with Editor-in-Chief Lisa Henderson and European Editor Julian Upton about outcomes-based con...
Episode 3: Pharma's Reputation
23 Feb 2018
Contributed by Lukas
Michelle Maskaly and Christen Harm talk to Devyn Smith, chief strategy officer and head of operations for Sigilon Therapeutics on the topic of pharma'...
Episode 2: JPMorgan Healthcare Conference 2018
12 Feb 2018
Contributed by Lukas
In this episode, Michelle Maskaly and Christen Harm speak with Marc O'Connor, chief operating officer at Curant Health, and Pharm Exec's Editor-in-Chi...
Episode 1: 2018 Pharmaceutical Trends
23 Jan 2018
Contributed by Lukas
In this podcast, Pharmaceutical Executive editors discuss the 2018 pharma trends, specifically biosimilars and eEnablement, and takeaways from the 201...